Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01798394 · ClinicalTrials.gov registry record · NA
Progesterone & Postpartum Relapse to Smoking
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT01798394 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 46 participants.
The verdict
NCT01798394, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The primary goal of this project is to investigate the potential efficacy of exogenous progesterone (with supplemental relapse prevention counseling) on postpartum relapse in new mothers. Also to determine the feasibility of enhanced compliance monitoring and identification of collateral factors effecting outcomes.
Interventions
- OTHER Placebo
- DRUG Progesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-06 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01798394
The ClinicalTrials.gov registry entry for NCT01798394 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01798394 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01798394 about?
NCT01798394 is a clinical study titled "Progesterone & Postpartum Relapse to Smoking". The primary goal of this project is to investigate the potential efficacy of exogenous progesterone (with supplemental relapse prevention counseling) on postpartum relapse in new mothers. Also to determine the feasibility of enhanced compliance monitoring and identification of collateral factors eff...
What is the current status of trial NCT01798394?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2014-06. Estimated completion is 2016-06.
What interventions are being tested in trial NCT01798394?
The interventions under investigation include: Placebo (OTHER), Progesterone (DRUG).
Who is sponsoring clinical trial NCT01798394?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.